Literature DB >> 30901115

Phyllodes tumor with a benign heterologous osseous component: a diagnostic challenge.

Lene Gaarsmand Christensen1, Tina Di Caterino1, Maj-Lis Talman2.   

Abstract

Phyllodes tumors (PTs) are rare fibroepithelial neoplasms of the breast and constitute 0.3-1% of all primary breast tumors. They should be characterized in to a benign, borderline or malignant category based on a combination of histological features. PTs can show heterologous components, typically sarcomatous, including osteosarcomatous and chondrosarcomatous. Benign heterologous components are exceedingly rare with only one prior reported case in the English literature. This case emphasizes how difficult establishing a correct diagnosis in PTs with heterologous components can be, especially when the tumor consists mainly of a benign heterologous component. We report the case of a 65 year old woman with a recurrent breast tumor initially misdiagnosed as benign osseous metaplasia. The tumor re-occurred as a malignant PT dominated by benign osseous and chondroid metaplasia. Multiple metastases consisting of primarily mature bone and cartilage were seen in the lungs. On microscopic revision and considering the clinical course the primary breast tumor was re-classified as a borderline PT.
© 2019 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Benign heterologous component; lung metastases; malignant transformation; phyllodes tumor; surgical pathology

Mesh:

Year:  2019        PMID: 30901115     DOI: 10.1111/apm.12949

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  2 in total

1.  Benign osseous metaplasia of the breast infiltrated by invasive pleomorphic lobular carcinoma: A case report.

Authors:  Hessa Aljhdali; Salena Bains; Vijaya Ganesh; Shekhar Kaneri; Abeer M Shaaban
Journal:  Int J Surg Case Rep       Date:  2022-09-30

2.  Myositis ossificans of the breast - A rare case report with radiologic-pathologic correlation.

Authors:  Keenan Boulnemour; Patrick Buoniconti; Sung Jik Cha; Todd Johnson
Journal:  Radiol Case Rep       Date:  2022-04-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.